HomeELEV • NASDAQ
add
Elevation Oncology Inc
Previous close
$0.47
Day range
$0.46 - $0.52
Year range
$0.41 - $5.83
Market cap
29.06M USD
Avg Volume
1.22M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.64M | 33.93% |
Net income | -10.44M | -32.12% |
Net profit margin | — | — |
Earnings per share | -0.18 | 5.26% |
EBITDA | -10.64M | -34.03% |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 93.18M | 12.13% |
Total assets | 95.63M | 7.34% |
Total liabilities | 35.60M | 3.85% |
Total equity | 60.02M | — |
Shares outstanding | 59.22M | — |
Price to book | 0.46 | — |
Return on assets | -26.35% | — |
Return on capital | -27.78% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -10.44M | -32.12% |
Cash from operations | -10.20M | 16.25% |
Cash from investing | 11.47M | 74.82% |
Cash from financing | -4.00K | -100.00% |
Net change in cash | 1.26M | 122.44% |
Free cash flow | -6.82M | 29.32% |
About
Founded
2019
Headquarters
Website
Employees
34
